Clinical trial

Sodium Pyruvate Therapy in COPD Patients

NCT00262613

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-09-01

PhasePHASE2

Study timeline

Study start (unknown)2004-09-01Date precision: month

Registry last updated2006-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

sodium pyruvate in 0.9% sodium chloride solutionDRUG

Sponsors & collaborators

Emphycorplead sponsor

Cellular Sciences, inc.collaborator

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00262613 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.